SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced preliminary total product and service revenue of approximately $31 million for the first quarter. This unaudited estimate, based on management’s preliminary financial analysis, is lower than the company’s previous guidance for product and service revenue […]
Reiterates full year guidance and extends cash runway to H2 2024 BRANFORD, Conn. — IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), the Superhuman Cell Company, today announced its preliminary unaudited revenue for the first quarter of 2022 and the transition to an integrated commercial and operational structure, which is intended to ensure a sustainable growth path. Recent […]
Ansa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by synthetic DNA from biologic drugs to biomanufacturing, and DNA-based data storage. Funding will advance next-generation technology platform, expand R&D and manufacturing facilities, grow multidisciplinary team, and launch DNA synthesis service. Ansa is solving current industry bottlenecks associated with synthesizing complex […]
Today, Finnish Organ-On-Chip startup Finnadvance announced that they’ve secured a €1.2 million seed financing round led by Finnish investor Athensmed. Several existing investors, such as deep tech VC Voima Ventures and early-stage VC Icebreaker, are participating in the funding round. In addition, the funding also includes a new investor: Takoa Invest. Finnadvance is a biotechnology start-up […]
Extension of previous funding round brings total raised to £7 million GBP (circa $9.2 million USD) Investment from Calculus Capital, Par Equity, and Scottish Enterprise Funding will support continued development of Axol’s human iPS cell lines and reagents, and expansion of its commercial team Cambridge, UK: Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, […]
Tolochenaz, Vaud, Switzerland — Nanolive SA, a leading live cell imaging and analysis company, announces today that it has successfully completed the initial closing of US $20 million in the Series C-1 equity financing round of investment, led by a US-based and NASDAQ listed life science investor, and Taiwania Capital, the leading life science venture capital […]
Recently, China’s leading company in animal cell culture technology and domestic serum-free culture media, Shanghai BioEngine Sci-Tech Co., LTD, announced the completion of a 200 million RMB Series B++ financing round. The financing was led by Legend Capital, followed by Addor Capital and Tsing Song Capital, and the old shareholder Hankang Capital continued to increase […]
Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 Fluidigm Board to Appoint Frank Witney, a Director Candidate Recommended by Caligan, if Casdin and Viking Transaction Closes Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting SOUTH SAN […]
Ampersand investment opportunity Syft is pleased to announce that it has reached an agreement with Ampersand Capital Partners (Ampersand) to invest $22.8m in Syft, subject to shareholder approval. Ampersand will subscribe to 17,545,000 convertible preference shares, equivalent to 19.6% of the total shares post-investment, at a price of $1.30 per share. Ampersand is a Boston, […]
Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting Parties to Terminate the Purchase Agreements if Stockholder Approval is Not Received on April 1 SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into an agreement with Casdin Capital, LLC (“Casdin”) and Viking Global Investors LP […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
